Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Depreciation and Depletion (2020 - 2025)

Historic Depreciation and Depletion for Neuroone Medical Technologies (NMTC) over the last 6 years, with Q4 2025 value amounting to $59945.0.

  • Neuroone Medical Technologies' Depreciation and Depletion rose 66.67% to $59945.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $239760.0, marking a year-over-year increase of 381.65%. This contributed to the annual value of $239363.0 for FY2025, which is 663.19% up from last year.
  • Latest data reveals that Neuroone Medical Technologies reported Depreciation and Depletion of $59945.0 as of Q4 2025, which was up 66.67% from $58745.0 recorded in Q3 2025.
  • Neuroone Medical Technologies' Depreciation and Depletion's 5-year high stood at $61015.0 during Q2 2025, with a 5-year trough of $13715.0 in Q1 2021.
  • Its 5-year average for Depreciation and Depletion is $42115.8, with a median of $52229.0 in 2023.
  • Per our database at Business Quant, Neuroone Medical Technologies' Depreciation and Depletion skyrocketed by 10446.79% in 2023 and then skyrocketed by 33.65% in 2025.
  • Over the past 5 years, Neuroone Medical Technologies' Depreciation and Depletion (Quarter) stood at $19582.0 in 2021, then soared by 54.79% to $30310.0 in 2022, then skyrocketed by 75.12% to $53078.0 in 2023, then rose by 12.19% to $59548.0 in 2024, then increased by 0.67% to $59945.0 in 2025.
  • Its Depreciation and Depletion was $59945.0 in Q4 2025, compared to $58745.0 in Q3 2025 and $61015.0 in Q2 2025.